[Immunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations]

Insights

The Spanish Association of Paediatrics

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • The Spanish Association of Paediatrics' Advisory Committee on Vaccines (CAV-AEP) annually updates its recommended immunization schedule for children in Spain.
  • Recent optimizations in the national schedule include pneumococcal and varicella vaccines for infants.

Purpose of the Study:

  • To present the CAV-AEP's updated, evidence-based immunization schedule for children residing in Spain.
  • To provide recommendations on both funded and unfunded vaccinations, including specific age groups and vaccination strategies.

Main Methods:

  • Review of current scientific evidence on vaccine efficacy and safety.
  • Analysis of the Spanish Ministry of Health's funded vaccination schedule.
  • Formulation of recommendations by the CAV-AEP.

Main Results:

  • The CAV-AEP recommends a 2+1 strategy for hexavalent (DTPa-IPV-Hib-HB) and 13-valent pneumococcal conjugate vaccines at 2, 4, and 12 months.
  • Booster doses for Tdap and poliomyelitis at age 6, and Tdap for adolescents and pregnant women are advised.
  • Two-dose schedules for MMR and varicella are recommended, with emphasis on improving human papillomavirus (HPV) vaccination coverage in girls and providing information to male adolescents.
  • Unfunded vaccination recommendations include meningococcal B (BEXSERO) and rotavirus vaccines for all infants, with CAV-AEP advocating for meningococcal B inclusion in the national schedule.
  • Annual influenza and hepatitis A vaccinations are recommended for at-risk populations.

Conclusions:

  • The CAV-AEP's updated schedule provides optimal vaccination strategies for children in Spain.
  • Key recommendations focus on completing primary vaccination series, administering booster doses, and expanding coverage for specific vaccines like HPV and meningococcal B.
  • The committee urges the incorporation of meningococcal B vaccine into the national funded schedule.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...